Stimulation of acetylcholine receptors impairs host defence during pneumococcal pneumonia

European Respiratory Journal

Volumn 33, Issue 2, 2009, Pages 375-381

  Giebelen, I A J ^a   Leendertse, M ^a   Florquin, S ^a   Van Der Poll, T ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Airway infection; Airway inflammation; Animal; Chemokines; Cytokines

Indexed keywords

CHEMOKINE; CHOLINERGIC RECEPTOR; CYTOKINE; GAMMA INTERFERON; MACROPHAGE INFLAMMATORY PROTEIN 2; NICOTINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HOST RESISTANCE; IMMUNE RESPONSE; INFLAMMATION; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; CHEMOKINES; FEMALE; IMMUNE SYSTEM; INFLAMMATION; LUNG; MICE; MICE, INBRED C57BL; NICOTINE; PNEUMONIA, PNEUMOCOCCAL; RECEPTORS, CHOLINERGIC; RECEPTORS, NICOTINIC; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS;

EID: 59649097929     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00103408     Document Type: Article

References (30)

1. Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 2007; 117: 289-296.
2. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384-388.
3. Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405: 458-462.
4. van Westerloo DJ, Giebelen IA, Meijers JC, et al. Vagus nerve stimulation inhibits activation of coagulation and fibrinolysis during endotoxemia in rats. J Thromb Haemost 2006; 4: 1997-2002.
5. Giebelen IA, van Westerloo DJ, LaRosa GJ, de Vos AF, van der Poll T. Stimulation of α7 cholinergic receptors inhibits lipopolysaccharide- induced neutrophil recruitment by a tumor necrosis factor-α-independent mechanism. Shock 2007; 27: 443-447.
6. Pavlov VA, Ochani M, Yang LH, et al. Selective α7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis. Crit Care Med 2007;35: 1139-1144.
7. Wang H, Liao H, Ochani M, et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 2004; 10: 1216-1221.
8. Su X, Lee JW, Matthay ZA, et al. Activation of the α7 nAChR reduces acid-induced acute lung injury in mice and rats. Am J Respir Cell Mol Biol 2007; 37: 186-192.
9. Giebelen IA, van Westerloo DJ, LaRosa GJ, de Vos AF, van der Poll T. Local stimulation of α7 cholinergic receptors inhibits LPS-induced TNF-α release in the mouse lung. Shock 2007; 28: 700-703.
10. Razani-Boroujerdi S, Singh SP, Knall C, et al. Chronic nicotine inhibits inflammation and promotes influenza infection. Cell Immunol 2004; 230: 1-9.
11. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005; 365: 63-78.
12. Mandell LA. Epidemiology and etiology of community- acquired pneumonia. Infect Dis Clin North Am 2004; 18:761-776.
13. Dessing MC, Knapp S, Florquin S, de Vos AF, van der Poll T. CD14 facilitates invasive respiratory tract infection by Streptococcus pneumoniae. Am J Respir Crit Care Med 2007;175: 604-611.
14. Knapp S, Wieland CW, van 't Veer C, et al. Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense. J Immunol 2004; 172:3132-3138.
15. Rijneveld AW, Weijer S, Florquin S, et al. Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide. Blood 2004; 103: 1702-1709.
16. Strieter RM, Belperio JA, Keane MP. Cytokines in innate host defense in the lung. J Clin Invest 2002; 109: 699-705.
17. Knapp S, Schultz MJ, van der Poll T. Pneumonia models and innate immunity to respiratory bacterial pathogens. Shock 2005; 24: Suppl. 1, 12-18.
18. Olson TS, Ley K. Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol 2002; 283: R7-R28.
19. Huston JM, Gallowitsch-Puerta M, Ochani M, et al. Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Crit Care Med 2007; 35: 2762-2768.
20. Campbell GD Jr. Commentary on the 1993 American Thoracic Society guidelines for the treatment of community-acquired pneumonia. Chest 1999; 115: Suppl. 3, 14S-18S.
21. Opal SM, Garber GE, LaRosa SP, et al. Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin α (activated). Clin Infect Dis 2003; 37: 50-58.
22. Chi ZL, Hayasaka S, Zhang XY, Cui HS, Hayasaka Y. A cholinergic agonist attenuates endotoxin-induced uveitis in rats. Invest Ophthalmol Vis Sci 2007; 48: 2719-2725.
23. Sadis C, Teske G, Stokman G, et al. Nicotine protects kidney from renal ischemia/reperfusion injury through the cholinergic anti-inflammatory pathway. PLoS ONE 2007; 2: e469.
24. Bergeron Y, Ouellet N, Deslauriers AM, Simard M, Olivier M, Bergeron MG. Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice. Infect Immun 1998; 66: 912-922.
25. Cormier A, Paas Y, Zini R, et al. Long-term exposure to nicotine modulates the level and activity of acetylcholine receptors in white blood cells of smokers and model mice. Mol Pharmacol 2004; 66: 1712-1718.
26. Speer P, Zhang Y, Gu Y, Lucas MJ, Wang Y. Effects of nicotine on intercellular adhesion molecule expression in endothelial cells and integrin expression in neutrophils in vitro. Am J Obstet Gynecol 2002; 186: 551-556.
27. Matsunaga K, Klein TW, Friedman H, Yamamoto Y. Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine. J Immunol 2001; 167: 6518-6524.
28. Pabst MJ, Pabst KM, Collier JA, et al. Inhibition of neutrophil and monocyte defensive functions by nicotine. J Periodontol 1995; 66: 1047-1055.
29. Nuorti JP, Butler JC, Farley MM, et al. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med 2000; 342: 681-689.
30. Sheffield JV, Root RK. Smoking and pneumococcal infection. N Engl J Med 2000; 342: 732-734.